Lv3
335 积分 2020-07-29 加入
Inhibitors and PROTACs of CDK2: challenges and opportunities
23小时前
已完结
An updated patent review of BRD4 degraders
2个月前
已完结
Updated patent review for Hematopoietic progenitor kinase (HPK1) inhibitors and degraders (2021-present)
6个月前
已完结
The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy
7个月前
已完结
In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy
9个月前
已完结
Relocalizing transcriptional kinases to activate apoptosis
1年前
已完结
LYTACs: An Emerging Tool for the Degradation of Non‐Cytosolic Proteins
1年前
已完结
Discovery of Potent Small-Molecule USP8 Inhibitors for the Treatment of Breast Cancer through Regulating ERα Expression
1年前
已完结
Discovery of Novel Phenoxyaryl Pyridones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with High Selectivity for the Second Bromodomain (BD2) to Potentially Treat Acute Myeloid Leukemia
1年前
已完结
Advancing Recyclable Thermosets through C═C/C═N Dynamic Covalent Metathesis Chemistry
1年前
已完结
Experimental and numerical investigation of DBT degradation via Rhodococcus spp. (SL-9) through the use of biological assisted method
4年前
已采纳
Correlation between total homocysteine and cerebral small vessel disease: A Mendelian randomization study
4年前
已采纳
Private–public mappings in human prefrontal cortex
5年前
已采纳
皖公网安备34019202002308
